UA Technology Innovation Awardee, Eugene Gerner, PhD, discusses his research

Eugene W. Gerner, PhD
Eugene W. Gerner, PhD

Eugene W. Gerner, PhD, professor of Cell Biology and Anatomy, Director of the Arizona Cancer Center’s Gastrointestinal (GI) Cancer program and BIO5 Institute member, is the 2010 University of Arizona Technology Innovation Award winner. He was honored March 23.

The Technology Innovation Award is given annually in recognition of exemplary innovative achievements in translating original ideas from the laboratory to the marketplace. Read more>>

Dr. Gerner, a University of Arizona faculty member since 1974, was honored for his development of a two-drug combination shown to reduce the risk of recurrent colorectal polyps, a precursor to colon cancer, by up to 95 percent with minimal toxicity.

Dr. Gerner is a co-founder of Cancer Prevention Pharmaceuticals, established to develop therapies to prevent cancer in people with elevated risks for the diseases. He also leads the Cancer Center’s prestigious federally funded Specialized Program of Research Excellence in GI cancers. He was named a 2009 Leading Edge Researcher during last year’s Innovation Day events.

Samantha Kendrick, a final-year PhD candidate in the Cancer Center’s Cancer Biology Graduate Interdisciplinary Program, was the Student Technology Innovation Award winner. She is the first female recipient among either faculty or student top honorees in the program’s seven-year history. Read more>>